Elanco to seek shareholder approval for board declassification and enhanced shareholder rights

Elanco Animal Health Inc

Board to seek shareholder approval at 2024 annual meeting to declassify Board of Directors.
Proposal also includes allowing shareholders to amend Bylaws and call special meetings under certain conditions.
Follows elimination of supermajority vote requirements last year; reflects shareholder engagement since IPO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.